Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Evolus
EOLS
$398M
| $64K | ﹤0.01% |
12,019
+5,883
| +96% | +$27.1K |
|
|
FARM
4727
DELISTED
Farmer Brothers
FARM
| $64K | ﹤0.01% |
8,812
+5,256
| +148% | +$42.3K |
|
4728
CALL
Fox Class A
FOXA
$24.6B
| $64K | ﹤0.01% |
2,400
-305,800
| -99% | -$8.26M |
|
4729
Galectin Therapeutics
GALT
$192M
| $64K | ﹤0.01% |
21,051
+7,669
| +57% | +$19.3K |
|
4730
Geospace Technologies
GEOS
$96M
| $64K | ﹤0.01% |
8,469
-2,654
| -24% | -$17.7K |
|
4731
Gilat Satellite Networks
GILT
$898M
| $64K | ﹤0.01% |
10,000
-172
| -2% | -$1.32K |
|
4732
GSI Technology
GSIT
$262M
| $64K | ﹤0.01% |
8,854
+3,569
| +68% | +$25.9K |
|
4733
Hawthorn Bancshares
HWBK
$274M
| $64K | ﹤0.01% |
3,657
+1,462
| +67% | +$23K |
|
4734
Orion Energy Systems
OESX
$43.6M
| $64K | ﹤0.01% |
+1,862
| New | +$76.2K |
|
4735
Organogenesis Holdings
ORGO
$309M
| $64K | ﹤0.01% |
16,447
+7,151
| +77% | +$25.8K |
|
4736
PUT
PPG Industries
PPG
$26.1B
| $64K | ﹤0.01% |
600
-5,000
| -89% | -$482K |
|
4737
ProQR Therapeutics
PRQR
$251M
| $64K | ﹤0.01% |
10,488
+7,135
| +213% | +$38.5K |
|
4738
SB Financial Group
SBFG
$164M
| $64K | ﹤0.01% |
+4,060
| New | +$58.5K |
|
4739
Stratus Properties
STRS
$158M
| $64K | ﹤0.01% |
3,237
+1,291
| +66% | +$21.9K |
|
4740
Teekay
TK
$980M
| $64K | ﹤0.01% |
27,002
-27,767
| -51% | -$85K |
|
4741
CALL
State Street SPDR S&P Retail ETF
XRT
$333M
| $64K | ﹤0.01% |
1,500
-73,300
| -98% | -$2.78M |
|
|
VOXX
4742
DELISTED
VOXX International Corporation Class A
VOXX
| $64K | ﹤0.01% |
11,007
-31,410
| -74% | -$156K |
|
|
PCTI
4743
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $64K | ﹤0.01% |
+9,693
| New | +$61.9K |
|
|
CIZN
4744
DELISTED
Citizens Holding Co.
CIZN
| $64K | ﹤0.01% |
+2,545
| New | +$57K |
|
|
PEI
4745
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $64K | ﹤0.01% |
3,137
-3,912
| -55% | -$70.5K |
|
4746
Princeton Bancorp
BPRN
$288M
| $63K | ﹤0.01% |
3,115
+1,256
| +68% | +$25.4K |
|
4747
CALL
Cardinal Health
CAH
$54.7B
| $63K | ﹤0.01% |
1,200
-108,500
| -99% | -$5.59M |
|
4748
C&F Financial
CFFI
$272M
| $63K | ﹤0.01% |
1,892
+782
| +70% | +$26.8K |
|
|
HOLX
4749
CALL
DELISTED
Hologic
HOLX
| $63K | ﹤0.01% |
1,100
-5,800
| -84% | -$285K |
|
4750
Legacy Housing
LEGH
$649M
| $63K | ﹤0.01% |
4,439
+2,519
| +131% | +$28.6K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.